Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Resonant Medical's radiation therapy guiding platform:

This article was originally published in Clinica

Executive Summary

Resonant Medical's Restitu system is a 3D ultrasound image-guided radiation therapy platform. Tumour position verification for patient realignment is crucial in the radiotherapy of many cancers, given that organs are prone to change shape and shift their internal position from one treatment day to the next, said the Montreal, Quebec-based firm. Restitu quantifies these changes in organ position and morphology, allowing doctors to achieve accurate patient positioning during external beam radiation therapy.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT054046

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel